NZ dollar rides optimism on unproven covid-19 treatment

NZ dollar rides optimism on unproven covid-19 treatment
Jenny Ruth
The New Zealand dollar rode a wave of optimism about a still-unproven covid-19 treatment which has been driving equities markets higher. At the same time, the market has been ignoring worse than expected US March-quarter GDP data and a downbeat economic assessment from the Federal Reserve. The kiwi was trading at 61.44 US cents at 5pm in Wellington from 60.93 cents at the same time yesterday. The trade-weighted index was at 69.11 from 68.78. Biopharmaceutical company Gilead has been talking up Remdesivir, a drug which proved ineffectiv...

More Markets

NZME shareholder Jim Grenon lifts investment in media firm
Markets

NZME shareholder Jim Grenon lifts investment in media firm

NZME shareholder and director Jim Grenon has lifted his investment in the media business for the second time in recent weeks, to just under 18%.A notice to the NZX on Monday stated Grenon had lifted his shareholding from 15.963% to 17.932%, after acquiring 3.7 million shares for...

‘Unusual’ volume of CCCFA changes in focus
Finance

‘Unusual’ volume of CCCFA changes in focus

Select committee mulls proposed changes to CCCFA, to report recommendations Oct 20.

F&P Healthcare urges Govt to shut patent loophole
Markets

F&P Healthcare urges Govt to shut patent loophole

The company says the current patent loophole threatens its NZ operations.

NZX 50 dips despite Fletcher Building's 4.6% gain
Markets Market Close

NZX 50 dips despite Fletcher Building's 4.6% gain

Pacific Edge shares gained after it said it got a step closer to Medicare approval.

Gregor Thompson 15 Sep 2025